Clinical trial
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
NCT04968548
Study timeline
Study start (actual)2021-09-17Date precision: day
Registry last updated2026-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
Blood collectionPROCEDURE
Sponsors & collaborators
Nucleix Ltd.lead sponsor
Mapped research locations
DurhamNorth Carolina, United States2CharlestonSouth Carolina, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1TorontoOntario, Canada1ClevelandOhio, United States1MontrealQuebec, Canada1MinneapolisMinnesota, United States1OrlandoFlorida, United States1RochesterNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04968548 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.